At list price, Wegovy and Zepbound cost roughly $1,000-1,400/month. For most people, stopping means regaining weight. So we're talking about potentially decades of medication. Is that worth it?
The Health Benefits
- 15-25% body weight reduction (vs ~5% with lifestyle alone)
- 20% reduction in cardiovascular events (SELECT trial)
- Diabetes prevention/remission in many patients
- Improved blood pressure, cholesterol, inflammation
- Quality of life improvements (mobility, energy, mental health)
- Reduced healthcare utilization for obesity-related conditions
The Health Economics Perspective
Health economists use a measure called QALY (quality-adjusted life year) to evaluate treatments. The question: how much is a year of healthy life worth?
The Institute for Clinical and Economic Review (ICER) analyzed GLP-1 cost-effectiveness:
- At current prices, GLP-1s exceed typical cost-effectiveness thresholds
- To be cost-effective at ~$150,000/QALY, prices would need to drop ~40-70%
- Long-term cardiovascular benefits may improve this calculation
- If used only in highest-risk patients, cost-effectiveness improves
Translation: At list price, these drugs are expensive relative to health gains compared to other interventions. But the calculation changes if you factor in prevented heart attacks, diabetes, and joint replacements.
The Personal Calculation
- What are my obesity-related health risks? (Higher risk = more benefit)
- What's the realistic alternative? (Prior failed attempts matter)
- Can I sustain this cost long-term?
- What's the opportunity cost? (What else could this money do?)
- What's my quality of life now vs. projected improvement?
Ways to Reduce Cost
- Insurance coverage: Many commercial plans cover with prior auth
- Manufacturer savings cards: Can reduce copays to $0-25 (commercial insurance only)
- Compounded versions: $150-300/month (quality varies)
- Telehealth bundles: $200-500/month all-in
- Patient assistance programs: For uninsured/underinsured
The Honest Take
For someone with severe obesity, multiple comorbidities, and failed prior attempts at weight loss, GLP-1 medications likely provide significant value—potentially life-saving benefits that would cost far more to treat as individual conditions.
For someone with modest overweight and no metabolic issues, the calculus is different. The benefit is primarily cosmetic, and $12,000+/year is expensive for that outcome.
Neither answer is wrong. It's a personal calculation based on your health situation, finances, and values.
- ICER cost-effectiveness analysis of GLP-1 medications.
- SELECT trial cardiovascular outcomes.
- Health economics research on obesity treatment value.
Ready to Get Started?
Compare verified GLP-1 providers. All include telehealth consultation + medication.
Affiliate Disclosure: We may earn a commission at no extra cost to you.